Clinical Trials

New Search
Title   Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry (SABLE)
Disease/Condition   Rheumatic Diseases
Eligibility Criteria   Ages Eligible for Study: 18 Years and older Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements
Principal Investigator   Chaim Putterman, MD
Contact Name   Nicole Jordan
Phone   (718) 920-6416
Contact Email
IRB/Protocol Number   IRB# 13-08-123-01
Status   Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No